{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T22:40:29Z","timestamp":1794868829875,"version":"4.9.1"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>This review focuses on the presentation and management of ichthyoses and highlights recent advances in treatment that hold promise for better targeted therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>The ichthyoses are a group of rare genetic diseases with a wide phenotypic spectrum, characterized most often by generalized hyperkeratosis and scaling with variable erythema. The highly visible scaling and frequent itch contribute to decreased quality of life. Management for ichthyosis focuses on symptomatic relief and scale reduction with emollients, keratolytics, and retinoids. Recent advances in immune profiling and genotype-phenotype mapping have increased understanding of ichthyosis and shifted focus to pathogenesis-based targeted therapies with emerging biologics, small molecular inhibitors, and gene therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>This article discusses clinical assessment and genotyping to make the diagnosis of specific forms of ichthyosis, provides guidance for management, and reviews new treatment options with systemic agents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000001264","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T01:41:48Z","timestamp":1687570908000},"page":"467-474","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Ichthyosis: presentation and management"],"prefix":"10.1097","volume":"35","author":[{"given":"Sneha","family":"Butala","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Yale New Haven Health \u2013 Bridgeport Site, Bridgeport, Connecticut; Pediatric Healthcare Associates, Shelton, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Mazereeuw-Hautier","sequence":"additional","affiliation":[{"name":"Centre for Rare Skin Diseases, Dermatology Department, Larrey Hospital, Paul Sabatier University, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"R1-20250730","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41572-022-00412-3","article-title":"Ichthyosis","volume":"9","author":"Gutierrez-Cerrajero","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20250730","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/pde.14221","article-title":"Transepidermal water loss in the orphan forms of ichthyosis","volume":"37","author":"Erickson","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/bjd.21687","article-title":"Distinct skin microbiome community structures in congenital ichthyosis","volume":"187","author":"Tham","year":"2022","journal-title":"Br J Dermatol"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaad.2009.11.020","article-title":"Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Soreze","volume":"63","author":"Oji","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1468-3083.2002.00477.x","article-title":"Collodion baby: a follow-up study of 17 cases","volume":"16","author":"Van Gysel","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/jdv.18043","article-title":"Proposal for a 6-step approach for differential diagnosis of neonatal erythroderma","volume":"36","author":"Cuperus","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R7-20250730","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jaad.2012.05.036","article-title":"Collodion baby: an update with a focus on practical management","volume":"67","author":"Prado","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/dermatopathology8020017","article-title":"Ichthyoses-A clinical and pathological spectrum from heterogeneous cornification disorders to inflammation","volume":"8","author":"Metze","year":"2021","journal-title":"Dermatopathology (Basel)"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/genes12010080","article-title":"Meta-analysis of mutations in ALOX12B or ALOXE3 identified in a large cohort of 224 patients","volume":"12","author":"Hotz","year":"2021","journal-title":"Genes (Basel)"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/429844","article-title":"Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis","volume":"76","author":"Kelsell","year":"2005","journal-title":"Am J Hum Genet"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/ped.12638","article-title":"Epidemiology, medical genetics, diagnosis and treatment of harlequin ichthyosis in Japan","volume":"57","author":"Shibata","year":"2015","journal-title":"Pediatr Int"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archdermatol.2011.9","article-title":"Harlequin ichthyosis: a review of clinical and molecular findings in 45 cases","volume":"147","author":"Rajpopat","year":"2011","journal-title":"Arch Dermatol"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/11311070-000000000-00000","article-title":"Ichthyosis: clinical manifestations and practical treatment options","volume":"10","author":"Oji","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/jamadermatol.2021.4242","article-title":"The genomic and phenotypic landscape of ichthyosis: an analysis of 1000 kindreds","volume":"158","author":"Sun","year":"2022","journal-title":"JAMA Dermatol"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/ced.13800","article-title":"Novel and recurrent mutations in keratin 1 cause epidermolytic ichthyosis and palmoplantar keratoderma","volume":"44","author":"Smith","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI64415","article-title":"Frequent somatic reversion of KRT1 mutations in ichthyosis with confetti","volume":"125","author":"Choate","year":"2015","journal-title":"J Clin Invest"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.1192280","article-title":"Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10","volume":"330","author":"Choate","year":"2010","journal-title":"Science"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/jamadermatol.2014.2525","article-title":"Phenotypic expansion in ichthyosis with confetti","volume":"151","author":"Choate","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/75977","article-title":"Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome","volume":"25","author":"Chavanas","year":"2000","journal-title":"Nat Genet"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"720","DOI":"10.2340\/00015555-2075","article-title":"Ichthyosis linearis circumflexa as the only clinical manifestation of netherton syndrome","volume":"95","author":"Guerra","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jaad.2007.03.039","article-title":"Treatment of ichthyosis \u2013 there is always something you can do! In Memoriam: Wolfgang K\u00fcster","volume":"57","author":"Traupe","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaad.2009.04.011","article-title":"Scaly skin and bath pH: rediscovering baking soda","volume":"62","author":"Milstone","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/PRS.0b013e3181c83192","article-title":"Active agents in common skin care products","volume":"125","author":"Draelos","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jaci.2015.08.013","article-title":"Petrolatum: barrier repair and antimicrobial responses underlying this \u201cinert\u201d moisturizer","volume":"137","author":"Czarnowicki","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1651-2227.1997.tb08902.x","article-title":"Salicylate intoxication using a skin ointment","volume":"86","author":"Chiaretti","year":"1997","journal-title":"Acta Paediatr"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1525-1470.2006.00236.x","article-title":"Acute percutaneous lactic acid poisoning in a child","volume":"23","author":"Ramirez","year":"2006","journal-title":"Pediatr Dermatol"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jaad.2013.12.005","article-title":"A review of toxicity from topical salicylic acid preparations","volume":"70","author":"Madan","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/pde.14408","article-title":"Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents","volume":"38","author":"Zaenglein","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/bjd.17203","article-title":"Management of congenital ichthyoses: European guidelines of care, part one","volume":"180","author":"Mazereeuw-Hautier","year":"2019","journal-title":"Br J Dermatol"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2340\/00015555-3087","article-title":"Tazarotene 0.015% cream as a potential topical agent for management of ichthyosis in Dorfman-Chanarin syndrome","volume":"99","author":"Niculescu","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"R31-20250730","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12516","article-title":"Lamellar ichthyosis associated bilateral pseudoainhum of fingers and toes successfully treated with tazarotene","volume":"30","author":"Behera","year":"2017","journal-title":"Dermatol Ther"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/pde.13240","article-title":"Ectropion improvement with topical tazarotene in children with lamellar ichthyosis","volume":"34","author":"Hanson","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"R33-20250730","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jamadermatol.2013.239","article-title":"Topical tazarotene for the treatment of ectropion in ichthyosis","volume":"149","author":"Craiglow","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1525-1470.2006.00252.x","article-title":"Erythrokeratoderma variabilis successfully treated with topical tazarotene","volume":"23","author":"Yoo","year":"2006","journal-title":"Pediatr Dermatol"},{"key":"R35-20250730","first-page":"346","article-title":"Topical tazarotene 0.05% versus glycolic acid 70% treatment in X-linked ichthyosis due to extensive deletion of the STS gene","volume":"85","author":"Cotellessa","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"R36-20250730","doi-asserted-by":"crossref","DOI":"10.1093\/ced\/llad033","article-title":"Phase 2B randomised CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosis","author":"Murrell","year":"2023","journal-title":"Clin Exp Dermatol"},{"key":"R37-20250730","first-page":"985","article-title":"Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne","volume":"5","author":"Laquieze","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"R38-20250730","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1529-8019.2012.01527.x","article-title":"Systemic retinoids in the management of ichthyoses and related skin types","volume":"26","author":"Digiovanna","year":"2013","journal-title":"Dermatol Ther"},{"key":"R39-20250730","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1468-3083.2008.02795.x","article-title":"Netherton's syndrome: successful treatment with isotretinoin","volume":"23","author":"Lazaridou","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"(Pt 2 Suppl)","key":"R40-20250730","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0190-9622(82)70053-2","article-title":"Pharmacokinetics of the retinoids isotretinoin and etretinate. A comparative review","volume":"6","author":"Brazzell","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"R41-20250730","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13023-018-0783-9","article-title":"Alitretinoin reduces erythema in inherited ichthyosis","volume":"13","author":"Onnis","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"R42-20250730","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/bjd.15668","article-title":"Efficacy and adverse events of oral isotretinoin for acne: a systematic review","volume":"178","author":"Vallerand","year":"2018","journal-title":"Br J Dermatol"},{"key":"R43-20250730","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4103\/0253-7613.106444","article-title":"Pseudotumor cerebri in a child treated with acitretin: a rare occurrence","volume":"45","author":"Sarkar","year":"2013","journal-title":"Indian J Pharmacol"},{"key":"R44-20250730","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaad.2020.01.052","article-title":"Ichthyosis affects mental health in adults and children: a cross-sectional study","volume":"83","author":"Sun","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R45-20250730","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.2005.06906.x","article-title":"Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years\u2019 experience on 23 patients","volume":"154","author":"Katugampola","year":"2006","journal-title":"Br J Dermatol"},{"key":"R46-20250730","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1067\/mjd.2001.113721","article-title":"Isotretinoin effects on bone","volume":"45","author":"DiGiovanna","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"(5 Pt 1)","key":"R47-20250730","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0190-9622(87)80292-X","article-title":"Etretinate and premature epiphyseal closure in children","volume":"17","author":"Glover","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"R48-20250730","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/jid.2011.189","article-title":"Pathogenesis-based therapy reverses cutaneous abnormalities in an inherited disorder of distal cholesterol metabolism","volume":"131","author":"Paller","year":"2011","journal-title":"J Invest Dermatol"},{"key":"R49-20250730","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaad.2019.08.043","article-title":"Topical cholesterol\/lovastatin for the treatment of porokeratosis: a pathogenesis-directed therapy","volume":"82","author":"Atzmony","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R50-20250730","doi-asserted-by":"crossref","first-page":"e1006566","DOI":"10.1371\/journal.pgen.1006566","article-title":"KLK5 and KLK7 ablation fully rescues lethality of netherton syndrome-like phenotype","volume":"13","author":"Kasparek","year":"2017","journal-title":"PLoS Genet"},{"key":"R51-20250730","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jid.2018.11.002","article-title":"Transglutaminase 1 replacement therapy successfully mitigates the autosomal recessive congenital ichthyosis phenotype in full-thickness skin disease equivalents","volume":"139","author":"Plank","year":"2019","journal-title":"J Invest Dermatol"},{"key":"R52-20250730","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jid.2016.08.036","article-title":"PNPLA1 deficiency in mice and humans leads to a defect in the synthesis of Omega-O-acylceramides","volume":"137","author":"Grond","year":"2017","journal-title":"J Invest Dermatol"},{"key":"R53-20250730","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jid.2020.07.035","article-title":"Preclinical evaluation of a modified herpes simplex virus type 1 vector encoding Human TGM1 for the treatment of autosomal recessive congenital ichthyosis","volume":"141","author":"Freedman","year":"2021","journal-title":"J Invest Dermatol"},{"key":"R54-20250730","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.3390\/ijms23052506","article-title":"Current strategies for the gene therapy of autosomal recessive congenital ichthyosis and other types of inherited ichthyosis","volume":"23","author":"Chulpanova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R55-20250730","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.jid.2022.03.022","article-title":"Transcriptomic analysis of the major orphan ichthyosis subtypes reveals shared immune and barrier signatures","volume":"142","author":"Kim","year":"2022","journal-title":"J Invest Dermatol"},{"key":"R56-20250730","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaci.2016.07.019","article-title":"An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis","volume":"139","author":"Paller","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R57-20250730","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.jid.2018.03.1523","article-title":"The major orphan forms of ichthyosis are characterized by systemic T-cell activation and Th-17\/Tc-17\/Th-22\/Tc-22 polarization in blood","volume":"138","author":"Czarnowicki","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R58-20250730","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaci.2018.03.021","article-title":"Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature","volume":"143","author":"Malik","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"R59-20250730","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/jamadermatol.2020.1019","article-title":"Secukinumab therapy for netherton syndrome","volume":"156","author":"Luchsinger","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R60-20250730","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/bjd.18892","article-title":"Successful treatment of Netherton syndrome with ustekinumab in a 15-year-old girl","volume":"183","author":"Volc","year":"2020","journal-title":"Br J Dermatol"},{"key":"R61-20250730","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.jid.2021.02.451","article-title":"Randomized, double-blind, placebo-controlled study of efficacy and safety of secukinumab to treat adults with ichthyoses","volume":"141","author":"Lefferdink","year":"2021","journal-title":"J Invest Dermatol"},{"key":"R62-20250730","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/pde.13995","article-title":"Autosomal recessive congenital ichthyosis due to homozygous variants in NIPAL4 with a dramatic response to ustekinumab","volume":"36","author":"Poulton","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"R63-20250730","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/pde.14478","article-title":"Hair and skin predict cardiomyopathies: Carvajal and erythrokeratodermia cardiomyopathy syndromes","volume":"38","author":"Sun","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"R64-20250730","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jaad.2017.10.026","article-title":"The spectrum of manifestations in desmoplakin gene (DSP) spectrin repeat 6 domain mutations: Immunophenotyping and response to ustekinumab","volume":"78","author":"Paller","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R65-20250730","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/bjd.19684","article-title":"Secukinumab for the treatment of SAM syndrome associated with desmoglein-1 deficiency","volume":"184","author":"Frommherz","year":"2021","journal-title":"Br J Dermatol"},{"key":"R66-20250730","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1056\/NEJMc1908531","article-title":"Imbalance in T-helper 17 cells and targeted therapy in an infant with SAM-like syndrome","volume":"381","author":"Hernandez-Martin","year":"2019","journal-title":"N Engl J Med"},{"key":"R67-20250730","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jaci.2021.08.024","article-title":"Netherton syndrome subtypes share IL-17\/IL-36 signature with distinct IFN-alpha and allergic responses","volume":"149","author":"Barbieux","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"R68-20250730","first-page":"310","article-title":"Dupilumab improves pruritus in netherton syndrome: a case study","volume":"9","author":"Inaba","year":"2022","journal-title":"Children (Basel)"},{"key":"R69-20250730","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/1346-8138.16253","article-title":"Successful treatment of netherton syndrome with dupilumab: a case report and review of the literature","volume":"49","author":"Wang","year":"2022","journal-title":"J Dermatol"},{"key":"R70-20250730","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00403-022-02325-3","article-title":"Secukinumab responses vary across the spectrum of congenital ichthyosis in adults","volume":"315","author":"Lefferdink","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"R71-20250730","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1525-1470.2011.01432.x","article-title":"Resource utilization and quality of life associated with congenital ichthyoses","volume":"28","author":"Kamalpour","year":"2011","journal-title":"Pediatr Dermatol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:02:54Z","timestamp":1753898574000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001264","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]}}}